Add GLP-1 Weight Loss to Your New York MedSpa

What is a medspa GLP-1 program in New York?

A medspa GLP-1 program is a prescription weight loss service that a medical spa adds to its treatment menu, typically featuring compounded semaglutide or tirzepatide prescribed through telehealth. For medspas in New York, the program runs under your existing brand: clients complete an online intake, meet with a provider licensed in New York by video, and receive medication from an FDA-registered 503A or 503B pharmacy if it is clinically appropriate. Telehealth Grow supplies the provider network, pharmacy connections, consent templates, EMR and subscription billing, so your team does not need to hire a medical director solely for weight loss. The result is a recurring monthly revenue line that pairs naturally with body contouring, skin tightening and wellness treatments you already offer.

Why New York is a strong market for a medspa GLP-1 program

New York has an estimated 20,002,427 residents (U.S. Census Bureau, 2025), ranking 4th among the 50 states and D.C., and its population has declined 1% since the 2020 Census.

Demand is concentrated in New York (8.6M), Buffalo (275K), Yonkers (213K) and Rochester (206K), but a telehealth model lets one brand serve patients statewide — including smaller towns and rural counties where in-person weight loss clinics are scarce.

The capital, Albany, and the rest of the state run primarily on Eastern Time, so patient support and provider availability can be scheduled around local business hours.

CDC BRFSS data (2020) put New York’s adult obesity rate at 25.7%, below the 31.3% median across U.S. states. Using that rate for the state’s roughly 15,601,900 adults gives an estimated 4,009,700 adults living with obesity — the core audience for provider-led GLP-1 care.

The Northeast posts lower obesity prevalence than the South or Midwest in CDC data, so winning here is about positioning: a polished, premium brand experience and responsive support.

That is the opportunity for medspas and aesthetic practices in New York: a large, recurring need that a branded, compliant medspa GLP-1 program can serve without opening a traditional medical practice.

New York telehealth rules to know before you launch

The American Association of Nurse Practitioners (AANP) classifies New York as a full practice state: nurse practitioners can evaluate patients, diagnose and prescribe under the licensing authority of the state board of nursing. That gives a GLP-1 program flexibility in how it staffs prescribers, although physician oversight is still valuable for protocols and complex cases.

• Provider licensure: the prescribing clinician must be licensed in the state where the patient is located at the time of the visit — here, New York.
• Telehealth prescribing: semaglutide and tirzepatide are not DEA-controlled substances, so they can generally be prescribed after a valid telehealth consultation. Adding controlled medications such as phentermine brings extra Ryan Haight Act and DEA telemedicine requirements.
• Ownership structure: corporate practice of medicine rules limit who may own a medical practice and vary by state. The MSO-PC model separates the business you own from the clinical practice that delivers care.
• Compounded medications: must come from state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities, and FDA compounding policy shifts as drug-shortage status changes.
• Advertising: Google and Meta require LegitScript certification for many telehealth and pharmacy ads — we support the application.

This section is general information, not legal advice. Regulations change, and Telehealth Grow’s compliance team verifies current New York requirements for your specific business during onboarding.

Revenue potential in New York

Here is an illustrative projection. If a medspa GLP-1 program in New York reached just 0.05% of the adults estimated to be living with obesity, and each active patient generated about $120 in monthly profit (the benchmark used in our revenue calculator), the numbers would look like this:

Illustration only, not a guarantee. Actual revenue depends on medication costs, dosages, pricing, telehealth visit fees, marketing spend and patient retention.